Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 29, 2013
Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases
Ashwin N Ananthakrishnan, Su-Chun Cheng, Tianxi Cai, et al.
Journal of Crohn'S & Colitis
|
February 25, 2014
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease
Ashwin N Ananthakrishnan, Andrew Cagan, Vivian S Gainer, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
January 20, 2022
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers
Hina Shah, Yating Wang, Su-Chun Cheng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 11, 2014
Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases
Ashwin N Ananthakrishnan, Su-Chun Cheng, Tianxi Cai, et al.
Clinical Breast Cancer
|
December 26, 2018
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade
Heather A Jacene, Trisha Youn, Pamela J DiPiro, et al.
Gynecologic Oncology Reports
|
March 1, 2024
Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer
Panagiotis A Konstantinopoulos, Niya Xiong, Carolyn Krasner, et al.
Clinical Genitourinary Cancer
|
April 3, 2016
Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
Kathleen M Mahoney, Susanna Jacobus, Rupal S Bhatt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 18, 2014
Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases
Ashwin N Ananthakrishnan, Andrew Cagan, Vivian S Gainer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 21, 2025
A pilot study of [<sup>18</sup>F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy
Thomas S C Ng, Mofei Liu, Matthew Robertson, et al.
Gynecologic Oncology
|
July 2, 2026
Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data
Lauren Roller, Ningxuan Zhou, Isha Atre, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 29, 2013
Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases
Ashwin N Ananthakrishnan, Su-Chun Cheng, Tianxi Cai, et al.
Journal of Crohn'S & Colitis
|
February 25, 2014
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease
Ashwin N Ananthakrishnan, Andrew Cagan, Vivian S Gainer, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
January 20, 2022
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers
Hina Shah, Yating Wang, Su-Chun Cheng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 11, 2014
Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases
Ashwin N Ananthakrishnan, Su-Chun Cheng, Tianxi Cai, et al.
Clinical Breast Cancer
|
December 26, 2018
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade
Heather A Jacene, Trisha Youn, Pamela J DiPiro, et al.
Gynecologic Oncology Reports
|
March 1, 2024
Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer
Panagiotis A Konstantinopoulos, Niya Xiong, Carolyn Krasner, et al.
Clinical Genitourinary Cancer
|
April 3, 2016
Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
Kathleen M Mahoney, Susanna Jacobus, Rupal S Bhatt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 18, 2014
Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases
Ashwin N Ananthakrishnan, Andrew Cagan, Vivian S Gainer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 21, 2025
A pilot study of [<sup>18</sup>F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy
Thomas S C Ng, Mofei Liu, Matthew Robertson, et al.
Gynecologic Oncology
|
July 2, 2026
Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data
Lauren Roller, Ningxuan Zhou, Isha Atre, et al.
Page
of 8